Terms: = Thyroid cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
66 results:
1. Pathology and new insights in thyroid neoplasms in the 2022 WHO classification.
Lebrun L; Salmon I
Curr Opin Oncol; 2024 Jan; 36(1):13-21. PubMed ID: 37975316
[TBL] [Abstract] [Full Text] [Related]
2. Large-data contextualizations of social determinant associations in pediatric head and neck cancers.
Fei-Zhang DJ; Chelius DC; Sheyn AM; Rastatter JC
Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):424-429. PubMed ID: 37712774
[TBL] [Abstract] [Full Text] [Related]
3. Analyzing County-level Social Vulnerabilities of Head and Neck Melanomas in the United States.
McCampbell L; Fei-Zhang DJ; Chelius D; Rastatter J; Sheyn A
Laryngoscope; 2024 Jan; 134(1):185-190. PubMed ID: 37341511
[TBL] [Abstract] [Full Text] [Related]
4. thyroid lymphoma.
Rovira A; Carroll P; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):83-88. PubMed ID: 36912220
[TBL] [Abstract] [Full Text] [Related]
5. A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?
Su J; Lu J; Zhang J; Wang M; Yan J; Lin S
Curr Opin Oncol; 2023 Mar; 35(2):132-144. PubMed ID: 36721897
[TBL] [Abstract] [Full Text] [Related]
6. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract] [Full Text] [Related]
7. Oligometastatic disease from differentiated thyroid cancer: best treatment schemes.
Colombo E; Ottini A; Licitra L
Curr Opin Oncol; 2023 Jan; 35(1):15-21. PubMed ID: 36475458
[TBL] [Abstract] [Full Text] [Related]
8. Treatment of adrenocortical carcinoma: oncological and endocrine outcomes.
Brönimann S; Garstka N; Remzi M
Curr Opin Urol; 2023 Jan; 33(1):50-58. PubMed ID: 36444650
[TBL] [Abstract] [Full Text] [Related]
9. Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy.
Jungels C; Pita JM; Costante G
Curr Opin Oncol; 2023 Jan; 35(1):1-9. PubMed ID: 36398690
[TBL] [Abstract] [Full Text] [Related]
10. Advanced imaging and theranostics in thyroid cancer.
Roseland ME; Dewaraja YK; Wong KK
Curr Opin Endocrinol Diabetes Obes; 2022 Oct; 29(5):456-465. PubMed ID: 36068937
[TBL] [Abstract] [Full Text] [Related]
11. MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives.
Saltiki K; Simeakis G; Karapanou O; Alevizaki M
Eur J Endocrinol; 2022 Sep; 187(3):R53-R63. PubMed ID: 35895692
[TBL] [Abstract] [Full Text] [Related]
12. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary thyroid cancer.
Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
[TBL] [Abstract] [Full Text] [Related]
13. Active Surveillance of thyroid Microcarcinomas: a Critical View.
Cernea CR; Matos LL; Eugênio C; Ferreira GM; Cerqueira YS; Leite AKN; Vanderlei FAB; de Carlucci D; Gotoda RN; Hojaij FC; Araújo-Filho VJF
Curr Oncol Rep; 2022 Jan; 24(1):69-76. PubMed ID: 35061193
[TBL] [Abstract] [Full Text] [Related]
14. Factors Affecting Central Node Metastasis and Metastatic Lymph Node Ratio in Papillary thyroid cancer.
Seok J; Ryu CH; Park SY; Lee CY; Lee YK; Hwangbo Y; Lee EK; Lee YJ; Kim TS; Kim SK; Jung YS; Ryu J
Otolaryngol Head Neck Surg; 2021 Oct; 165(4):519-527. PubMed ID: 33560176
[TBL] [Abstract] [Full Text] [Related]
15. Predictive Value of Delphian Lymph Node Metastasis in the thyroid cancer.
Kim DH; Kim SW; Hwang SH
Laryngoscope; 2021 Sep; 131(9):1990-1996. PubMed ID: 33493364
[TBL] [Abstract] [Full Text] [Related]
16. Small cell lung cancer with thyroid gland oligometastasis: A case report.
Tsutsui T; Yamaki H; Kumagai T; Omori C; Kobayashi H; Kakizaki Y; Miyashita Y
Thorac Cancer; 2021 Feb; 12(3):387-390. PubMed ID: 33319473
[TBL] [Abstract] [Full Text] [Related]
17. Differentiated thyroid cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic in medullary thyroid cancer: the role of microRNA in tumorigenesis and prognosis.
Manso J; Censi S; Mian C
Curr Opin Oncol; 2021 Jan; 33(1):9-15. PubMed ID: 33093335
[TBL] [Abstract] [Full Text] [Related]
19. Treating papillary and follicular thyroid cancer in children and young people: Single UK-center experience between 2003 and 2018.
de Jong MC; Gaze MN; Szychot E; Rozalén García V; Brain C; Dattani M; Spoudeas H; Hindmarsh P; Abdel-Aziz TE; Bomanji J; Shankar A; Stoneham S; Morley S; Beale T; Jawad S; Otero S; Proctor I; Amin S; Butler G; Hewitt RJ; Kurzawinski TR
J Pediatr Surg; 2021 Mar; 56(3):534-539. PubMed ID: 32838975
[TBL] [Abstract] [Full Text] [Related]
20. Is Familial Nonmedullary thyroid cancer A More Aggressive Type of thyroid cancer?
Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M
Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812
[TBL] [Abstract] [Full Text] [Related]
[Next]
